172060 Sigma-AldrichAndrographolide - CAS 5508-58-7 - Calbiochem
A bicyclic diterpenoid lactone that displays anti-viral, anti-inflammatory, anti-apoptotic, and anti-hyperglycemic properties.
More>> A bicyclic diterpenoid lactone that displays anti-viral, anti-inflammatory, anti-apoptotic, and anti-hyperglycemic properties. Less<<同義語: Andro
お勧めの製品
概要
Replacement Information |
---|
主要スペック表
CAS # | Empirical Formula |
---|---|
5508-58-7 | C₂₀H₃₀O₅ |
価格&在庫状況
カタログ番号 | 在庫状況 | 包装 | Qty/Pk | 価格 | 数量 | |
---|---|---|---|---|---|---|
172060-50MGCN |
|
樹脂アンプル | 50 mg |
|
— |
References | |
---|---|
References | Xia, Y.F., et al. 2004. J. Immunol. 173, 4207. Chen, J.H., et al. 2004. Biochem. Pharmacol. 67, 1337. Yu, B.C., et al. 2003. Planta Med. 69, 1075. |
Product Information | |
---|---|
CAS number | 5508-58-7 |
ATP Competitive | N |
Form | Off-white solid |
Hill Formula | C₂₀H₃₀O₅ |
Chemical formula | C₂₀H₃₀O₅ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | NF-κB and AP-1 activation |
Primary Target IC<sub>50</sub> | ≤ 15 µM against NF-κB and AP-1 activation |
Purity | ≥95% by TLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | LU3490750 |
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
カタログ番号 | GTIN |
172060-50MGCN | 04055977222883 |
Documentation
Andrographolide - CAS 5508-58-7 - Calbiochem (M)SDS
タイトル |
---|
Andrographolide - CAS 5508-58-7 - Calbiochem 試験成績書(CoA)
タイトル | ロット番号 |
---|---|
172060 |
参考資料
参考資料の概要 |
---|
Xia, Y.F., et al. 2004. J. Immunol. 173, 4207. Chen, J.H., et al. 2004. Biochem. Pharmacol. 67, 1337. Yu, B.C., et al. 2003. Planta Med. 69, 1075. |